Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03299959 · ClinicalTrials.gov registry record · NA
Agili-C™ Implant Performance Evaluation
A NA study, sponsored by Smith & Nephew.
- Completed
- Registry status
- NA
- Development phase
- 251
- Enrollment target
NCT03299959 is a NA study that has completed, run by Smith & Nephew. The registered enrollment target is 251 participants.
The verdict
NCT03299959, a NA study, has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- NA
- Development phase
- 251 participants
- Enrollment target
Study Summary
The current study compares the efficacy and safety of the Agili-C implant to Surgical Standard of Care treatment in patients suffering from joint surface lesions of the knee. The patient population is heterogeneous, involving different kinds of joint surface lesions: focal cartilage lesions, osteochondral defects and mild to moderate osteoarthritis, including multiple defects.
Interventions
- DEVICE Agili-C implant
- PROCEDURE SSOC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2017-09-25 |
| Est. Completion | 2024-11-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03299959
The ClinicalTrials.gov registry entry for NCT03299959 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Agili-C implant is the first listed.
NCT03299959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03299959 about?
NCT03299959 is a clinical study titled "Agili-C™ Implant Performance Evaluation". The current study compares the efficacy and safety of the Agili-C implant to Surgical Standard of Care treatment in patients suffering from joint surface lesions of the knee. The patient population is heterogeneous, involving different kinds of joint surface lesions: focal cartilage lesions, osteoch...
What is the current status of trial NCT03299959?
This trial is currently completed. It is a NA study. The enrollment target is 251 participants. The study started on 2017-09-25. Estimated completion is 2024-11-14.
What interventions are being tested in trial NCT03299959?
The interventions under investigation include: Agili-C implant (DEVICE), SSOC (PROCEDURE).
Who is sponsoring clinical trial NCT03299959?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.